Inovio Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Inovio Pharmaceuticals

01/03/2023 22:05

* Inovio Pharmaceuticals Inc  INO.OQ  reported a quarterly
adjusted loss of 21 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 17 cents per share.
    * Revenue fell 85.2% to $124.00 thousand from a year ago;
analysts
expected $339.20 thousand. 
    * Inovio Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 21 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Inovio Pharmaceuticals Inc shares had fallen by 19.2% this
quarter.
    * The company reported a quarterly loss of $54.46 million.
    * Wall Street's median 12-month price target for Inovio
Pharmaceuticals Inc is $2.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 10:05 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.17          -0.21          Missed
 Sep. 30 2022      -0.30          -0.15          Beat
 Jun. 30 2022      -0.31          -0.46          Missed
 Mar. 31 2022      -0.34          -0.36          Missed